Table 3. Prognostic factors for cancer-specific survival in 169 patients with bladder cancer.
| Variables | Patients (n=169) | Category or characteristics | CSS | CSS | |||
|---|---|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | ||||
| Sex | 24/145 | Female/male | 0.656 (0.199–2.159) | 0.488 | – | – | |
| Age, years | 90/79 | >65/≤65 | 1.942 (0.935–4.033) | 0.075 | – | – | |
| T stage | 109/60 | T1–2/T3–4 | 2.020 (1.002–4.071) | 0.049 | – | – | |
| N stage | 140/29 | N0/N1–3 | 3.110 (1.369–7.065) | 0.007 | 3.078 (1.282–7.388) | 0.012 | |
| Hypertension | 64/105 | Yes/no | 0.558 (0.250–1.245) | 0.154 | – | – | |
| Diabetes | 26/143 | Yes/no | 1.568 (0.677–3.632) | 0.293 | – | – | |
| Cardiovascular or cerebrovascular diseases | 27/142 | Yes/no | 0.789 (0.303–2.058) | 0.629 | – | – | |
| RDW | 30/139 | ≥0.1395/<0.1395 | 2.774 (1.311–5.873) | 0.008 | 2.384 (1.062–5.355) | 0.035 | |
| RBC, 1012/L | 28/141 | >3.62/≤3.62 | 0.270 (0.129–0.564) | 0.001 | 0.400 (0.128–1.253) | 0.116 | |
| CRP, mg/L | 54/115 | >5/≤5 | 3.813 (1.893–7.684) | <0.001 | 2.966 (1.338–6.573) | 0.007 | |
| Hemoglobin | 36/133 | ≥110/<110 | 0.429 (0.202–0.911) | 0.028 | 1.781 (0.531–5.965) | 0.350 | |
| Primary/recurrence | 92/77 | Primary/recurrence | 1.048 (0.522–2.106) | 0.894 | – | – | |
| Single/multiple | 61/108 | Single/multiple | 0.694 (0.338–1.422) | 0.318 | – | – | |
Single: single bladder cancer mass; multiple: two or more bladder cancer masses; primary: primary bladder cancer; recurrence: recurrent bladder cancer. CSS, cancer-specific survival; HR, hazard ratio; CI, confidence interval; RDW, red blood cell distribution width; RBC, red blood cell; CRP, C-reactive protein.